VIA
NVAX icon

Vident Investment Advisory’s Novavax NVAX Stock Holding History

Vident Investment Advisory’s Portfolio NVAX Stock Details NVAX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q1 		– Sell
-3,936
Closed -$563K – 1324
2021
Q4 		$563K Sell
3,936
-436
-10% -$74.9K 0.01% 887
2021
Q3 		$906K Sell
4,372
-1,723
-28% -$380K 0.03% 710
2021
Q2 		$1.29M Buy
6,095
+2,174
+55% +$398K 0.04% 584
2021
Q1 		$711K Buy
+3,921
New +$781K 0.02% 699

Other funds holding NVAX

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Susquehanna International Group
Susquehanna International Group Bala Cynwyd, Pennsylvania $893B AUM 36.07% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Coatue Management
Coatue Management New York $29.1B AUM 96.54% 1-Year Est. Return
RCM
RA Capital Management Boston, Massachusetts $9.44B AUM 157.3% 1-Year Est. Return
Norges Bank
Norges Bank Oslo, Norway $935B AUM
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

Vident Investment Advisory's NVAX Position: Q1 2022 in Review

Vident Investment Advisory sold out of Novavax (NVAX) in Q1 2022, closing a stake of 3,936 shares — an estimated $563K sold.

Vident Investment Advisory first reported a position in NVAX in Q1 2021 and held it in 4 quarters. The position peaked at $1.29M in Q2 2021. 381 funds tracked by Wall St. Rank hold NVAX as of Q1 2022.

  • Vident Investment Advisory reported no remaining Novavax position as of Q1 2022 after selling out during the quarter.
  • Vident Investment Advisory sold 3,936 Novavax shares in Q1 2022, an estimated $563K.
  • Vident Investment Advisory first reported a position in Novavax in Q1 2021 and held it in 4 quarters.
  • Vident Investment Advisory's Novavax position peaked at $1.29M in Q2 2021.
  • 381 funds tracked by Wall St. Rank held Novavax as of Q1 2022.

Based on Vident Investment Advisory's 13F filing for Q1 2022, filed 16 May 2022.